The asymmetric synthesis of (R)-o-chloromandelic acid, a key intermediate for the anti-thrombotic agent clopidogrel, via the almond meal catalyzed hydrocyanation of 2-chlorobenzaldehyde and subsequent acidic hydrolysis was developed into an industrially viable procedure. The use of a minimum amount of water consistent with enzyme activity and a slow feed of the reactants were the keys to obtaining (R)-2-chloromandelonitrile in a high (98%) yield and satisfactory (90%) enantiomeric excess. Acidic hydrolysis of the nitrile followed by crystallization from toluene afforded enantiopure (ee > 99%) (R)-2-chloromandelic acid.
Read full abstract